about
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageinMechanisms of tolerance induction in allergic disease: integrating current and emerging concepts.Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in ChildrenNanoparticle-allergen complexes for allergen immunotherapy.Immunotherapy for house dust mite sensitivity: where are the knowledge gaps?The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice.A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol.Characterisation of CD154+ T cells following ex vivo birch allergen stimulation defines a close relationship between T cell subsets in healthy volunteers.Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects.Persistence and evolution of allergen-specific IgE repertoires during subcutaneous specific immunotherapyReduction in allergen-specific IgE binding as measured by microarray: A possible surrogate marker for effects of specific immunotherapy.Oral immunotherapy for treatment of egg allergy in children.Secondhand smoke in combination with ambient air pollution exposure is associated with increasedx CpG methylation and decreased expression of IFN-γ in T effector cells and Foxp3 in T regulatory cells in children.Sublingual Immunotherapy Induces Regulatory Function of IL-10-Expressing CD4(+)CD25(+)Foxp3(+) T Cells of Cervical Lymph Nodes in Murine Allergic Rhinitis Model.Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes.Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analysesPassive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy.Allergen immunotherapy for allergic respiratory diseasesThe site of allergen expression in hematopoietic cells determines the degree and quality of tolerance induced through molecular chimerismExposure to SIV in utero results in reduced viral loads and altered responsiveness to postnatal challenge.Sublingual Immunotherapy for Asthma: Affects T-Cells but Does not Impact Basophil ActivationA possible role for neutrophils in allergic rhinitis revealed after cellular subclassificationUpdate on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy.Developments in the field of allergy in 2011 through the eyes of Clinical and Experimental Allergy.Pathophysiology of and potential new therapies for allergic rhinitis.Developments in the field of allergy in 2012 through the eyes of Clinical & Experimental Allergy.Food allergy and the oral immunotherapy approach.Phase II drugs under investigation for allergic conjunctivitis.Advances in synthetic peptide immuno-regulatory epitopes.Immunotherapy for cow's milk allergy.Novel approaches and perspectives in allergen immunotherapy.Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.Dermatophagoides pteronyssinus immunotherapy changes the T-regulatory cell activity.Successful desensitization in a boy with severe cow's milk allergy by a combination therapy using omalizumab and rush oral immunotherapy.The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow's milk- and peanut allergy models.Antigen-specific immunotherapy regulates B cell activities in the intestine.Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy.Oral Immunotherapy for Treatment of Immunoglobulin E-Mediated Food Allergy: The Transition to Clinical Practice.Upregulated levels of human β-defensins in patients with seasonal allergic rhinitis after allergen-specific immunotherapy treatment.Post-treatment efficacy of discontinuous treatment with 300IR 5-grass pollen sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis.
P2860
Q28077951-50512383-F63F-4540-AE47-E68DC6DB1063Q30371304-889A6674-F203-4F87-B9EB-29E650EFEF55Q33586188-D3EDEC8B-D466-4CB9-BF85-4118799EE026Q33834985-E71FB1F4-0831-4655-A4A1-A97B0948CC65Q34445398-33C6AE84-0B50-4CEB-8D6F-E40E970B98B5Q34522164-8F7893D2-815D-402F-B948-E98B70E12D19Q34548671-3A7BFC5C-799F-4CBC-AA9A-43204715BD10Q34632593-48B52C74-04DA-439F-A496-9291C505CD8CQ35828399-29A27B52-D249-446B-819F-018DB4EE063AQ35838733-D53CB5E2-BFDC-4C4A-8652-93D4894F2D38Q36024279-9E85C372-EAE4-4CA1-BAE2-760CEBDC16A3Q36180099-CDC8ACD4-F098-4FF2-8690-F49204D5C8BDQ36353731-EE3DFCF6-345D-4300-91E1-D0AC3285E765Q36355490-8B4C1C0D-7E6A-444D-950D-8E49EBD25A5DQ36379784-4C32EE07-8526-43EE-8FB3-89F0A54919FDQ36411170-C57BB7A7-B062-4E93-985B-78A3FC19D344Q36795677-80998F5C-0417-4967-9F60-15E3A3D45ECCQ36864947-00CF6293-4C88-4D47-ABD1-8F02F1EFED12Q37276177-37375360-E334-4A85-ADB3-243C833DC2B5Q37400356-7A702E13-B6E9-4218-9D9B-DF0014056DABQ37653676-7FBF6FA1-C15F-42BE-82B7-6F1973510DD9Q37685898-D966FD91-D38F-4555-8E22-D846FB24AB04Q37732900-C775E0D5-18C4-481D-B052-E821DECC3577Q38062586-4A40874E-FAEE-4CF2-AA31-C25999EB6421Q38063483-6D23DB32-EE44-40C0-B8DB-4CE190733445Q38151900-CFCD041E-6641-4C9F-A53C-E81BDA1042A8Q38229885-93E351B8-2C59-4A1E-B7F8-4EA753BF98A5Q38234039-B92F55C1-BFE8-420F-B81F-E10626F95FA8Q38268100-763A3CA4-354C-41A3-B496-5EB3ACD4FA6DQ38639550-719D6C6A-345A-4CDF-BD88-2904B331DC02Q39103046-0822BF31-FCE0-4965-81A5-0535647766A2Q39115606-5D1BE648-A492-4E41-8B3E-D67952BF7C8AQ41697162-D3080C1B-BD42-4E30-9EFB-CA2E2D6865D5Q41952022-B3F2442E-0D74-4286-94E9-C0CA46497197Q42079184-B672EF0C-12D7-46FC-8119-A6FFEDCBDB28Q42130584-A33EDDC8-476A-49ED-8096-2CA32EAF25B7Q42153928-F177AC21-BD22-4BD0-A468-87D22B123B03Q42701375-B02E54CB-65EA-40A6-8B6C-1D8F01D93337Q44201691-114AD8B7-8C8C-436F-906F-E3C8A8DA51F0Q44987294-1A8BCB1C-A05D-4245-A5CB-A8E8E9B36A66
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms of immunotherapy to aeroallergens.
@en
Mechanisms of immunotherapy to aeroallergens.
@nl
type
label
Mechanisms of immunotherapy to aeroallergens.
@en
Mechanisms of immunotherapy to aeroallergens.
@nl
prefLabel
Mechanisms of immunotherapy to aeroallergens.
@en
Mechanisms of immunotherapy to aeroallergens.
@nl
P2860
P1476
Mechanisms of immunotherapy to aeroallergens.
@en
P2093
M H Shamji
S R Durham
P2860
P304
P356
10.1111/J.1365-2222.2011.03804.X
P577
2011-07-15T00:00:00Z